NCT06959706 2026-04-16
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Tagworks Pharmaceuticals BV
Phase 1 Recruiting
Tagworks Pharmaceuticals BV
M.D. Anderson Cancer Center
Providence Health & Services
National Institutes of Health Clinical Center (CC)
AstraZeneca
Peking University People's Hospital
Canadian Cancer Trials Group
Case Comprehensive Cancer Center
University Hospital, Toulouse
Chinese University of Hong Kong
Merck Sharp & Dohme LLC
Stanford University